Blood Cell Count and the Presence or Absence of Infection in Venous Ulcers Treated With Platelet-Rich Plasma.


Journal

Wounds : a compendium of clinical research and practice
ISSN: 1943-2704
Titre abrégé: Wounds
Pays: United States
ID NLM: 9010276

Informations de publication

Date de publication:
May 2021
Historique:
entrez: 9 8 2021
pubmed: 10 8 2021
medline: 29 10 2021
Statut: ppublish

Résumé

In general, chronic wounds are colonized by bacteria; however, when microorganisms start to multiply at higher levels, wounds can become infected, causing prolongation of the inflammatory phase and retardation of collagen synthesis and epithelialization. The objective of this study was to evaluate the presence of infection in venous ulcers after 12 weeks of treatment with autologous platelet-rich plasma (PRP) and determine global white blood cell counts. This case series study involved a sequential sample of 17 patients with venous ulcers treated with PRP for 12 weeks. Descriptive and inferential statistical analysis was performed using the McNemar test and χ² test. At baseline, 10 patients (58.8%) had wound infection. During the sixth week of treatment with PRP, only 3 patients (17.6%) continued to exhibit wound infection. After 12 weeks of PRP treatment, only 1 patient (5.9%) continued to exhibit wound infection. McNemar and χ² tests used to assess the presence of infection in the intervention group produced a P value of .0039 for a comparison of baseline and week 6 and a P value of .0078 for a comparison of baseline and week 12. These results demonstrated significant differences from baseline at both 6 weeks and 12 weeks of treatment, with greater significance at 12 weeks. There was no relationship between global white blood cell count and the presence of infection. After intervention with PRP, 94% of patients experienced improvement concerning the infection of ulcers.

Identifiants

pubmed: 34370679

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

113-118

Auteurs

Beatriz Guitton Renaud Baptista de Oliveira (BGRB)

Universidade Federal Fluminense, Rio de Janeiro, Brazil.

Joyce Beatriz de Abreu Castro (JBA)

Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.

Bruna Maiara Ferreira Barreto Pires (BMFB)

Universidade Federal Fluminense, Rio de Janeiro, Brazil.

Márcia de Assunção Ferreira (M)

Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.

Jane Marcy Neffá Pinto (JMN)

Universidade Federal Fluminense, Rio de Janeiro, Brazil.

Lenise Arneiro Teixeira (LA)

Universidade Federal Fluminense, Rio de Janeiro, Brazil.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH